✦ LIBER ✦

Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: The EPICAL study

✍ Scribed by M. Echemann; F. Zannad; S. Briançon; Y. Juillière; P.M. Mertès; J.M. Virion; J.P. Villemot; EPICAL Investigators

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of angiotensin-converting enzyme inh

✍ Edward F. Philbin; Thomas A. Rocco Jr. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 902 KB

Angiotensin-converting enzyme inhibitors

✍ Gary E Sander; James J McKinnie; Stanley S Greenberg; Thomas D Giles 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 481 KB

Reasons for Underuse of Angiotensin-Conv

✍ Bradley A Bart; MD; Wendy A Gattis; PharmD; Susan J Diem; MD; MPH; Christopher M 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Angiotensin-converting-enzyme inhibitors

✍ Gilles R Dagenais; Janice Pogue; Kim Fox; Marteen L Simoons; Salim Yusuf 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 105 KB

Predictors of decreased renal function i

✍ Eric L. Knight; Robert J. Glynn; Kevein M. McIntyre; Helen Mogun; Jerry Avorn 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Effects of candesartan in patients with

✍ John JV McMurray; Jan Östergren; Karl Swedberg; Christopher B Granger; Peter Hel 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 96 KB